Skip to main content

Table 4 Expected costs per patient by treatment and by time period, BAT + GDT vs. GDT alone, 2018 US Dollars (HF hospitalization rate relative reduction = 25%)

From: Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States

Time period (a)

BAT + GDT

GDT alone

Difference

6 Months

$43,600

$14,074

$29,526

1 Year

$53,141

$28,093

$25,047

2 Years

$67,325

$58,485

$8,840

3 Years

$80,565

$90,086

($9,521)

  1. (a) time period is marked by the implantation of the BAT device; 6-month data pertains to the BeAT-HF clinical trial, whereas years 1, 2 and 3 are based on extrapolations (see text)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us